The Role of Adjuvant Radiation in Uterine Sarcomas

This publication has 25 references indexed in Scilit:

• Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
  Gynecologic Oncology, 2008
• Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
  European Journal Of Cancer, 2008
• A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus☆
  Gynecologic Oncology, 2007
• Prognostic factors and outcome in women with uterine sarcoma
  European Journal of Surgical Oncology, 2007
• Malignant mixed müllerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Results of Primary and Adjuvant Radiotherapy in the Treatment of Mixed Müllerian Tumors of the Corpus Uteri
  Gynecologic Oncology, 1999
• Uterine sarcomas in Norway 1956–1992: Incidence, survival and mortality
  European Journal Of Cancer, 1997
• Retrospective analysis of 318 cases of uterine sarcoma
  European Journal of Cancer and Clinical Oncology, 1991
• Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri
  American Journal of Roentgenology, 1976
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958